Skip to content

A Comparison of Anatomically Aligned Versus Conventional in Unilateral Total Knee Arthroplasty

A Comparison of Anatomically Aligned Versus Conventional in Unilateral Total Knee Arthroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04181528
Enrollment
100
Registered
2019-11-29
Start date
2019-12-01
Completion date
2022-12-31
Last updated
2019-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anatomically Aligned Total Knee Arthroplasty, Knee Osteoarthritis

Brief summary

Total knee arthroplasty(TKA) is a successful orthopedic surgery with excellent clinical outcome and survival. However, there are concerns about patient satisfaction in previous reports, and dissatisfaction rate of 15-30% is reported in clinical outcomes(PROMs) of some studies. Therefore, for improving the patient's outcome and satisfaction after total knee arthroplasty, it is necessary to change the design of the conventional total knee arthroplsaty implant. The knee is a joint structure with several dynamic functions, and not only the skeletal structure but also the soft tissue balance plays an important role in the function of the knee joint. New implants are being developed to overcome the limitations of conventional TKA implant, including the Journey II Bi-cruciate substituting total knee system (JII-BCS; Smith & Nephew). JII-BCS implant has normal articular geometry, more anatomical femoral shape, lateral tibial convex geometry, and asymmetrical tibial plateau, anterior and posterior cams, which has been shown in experimental studies to produce nearly normal knee movement by reproducing the actual normal anatomical alignment in vivo. The clinical results of the kinematic effects of this anatomcally aligned change are insufficient, and there is also a lack of comparative studies with conventional total knee arthroplasty implant. The purpose of this study is to compare outcomes between anatomically aligned TKA(JII-BCS) and conventional TKA(Legion total knee system, Smith & Nephew). This study is a randomized controlled study in patients undergoing unilateral total knee arthroplasty. A patient will undergo unilateral TKA with anatomically aligned or conventional TKA implant. The implant is determined using a random number table. Radiologic parameter, patients preference and clinical results was investigated in patients who received unilateral TKA during minimum 2 year follow up.

Interventions

DEVICETotal knee arthroplasty implant

In patients undergoing unilateral TKA, decide the implant of TKA (anatomically aligned or conventional TKA implant) will be decided using ramdon number table

Sponsors

The Catholic University of Korea
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients for bilateral total knee arthroplasty * having medicare insurance

Exclusion criteria

* Rheumatoid arthritis * Other inflammatory arthritis * Crystal-induced arthritis * Septic arthritis * Neuropsychiatric patients * Previous knee operation history * Neuropsychiatric patients * Patients with preoperative severe limitation of motion (Flexion contracture ≥ 20, range of motion ≤ 90) * Patients with preoperative severe defomity of knee alignment (Varus or valgus angle ≥ 15) * Severe obese patients (BMI ≥ 40)

Design outcomes

Primary

MeasureTime frame
Change in Western Ontario and McMaster Universities Index(WOMAC index)hange from baseline score to score of postoperative1 year

Secondary

MeasureTime frame
Change in Knee Society ScoreChange from baseline score to score of postoperative1 year
Change in Range of MotionChange from baseline Range of Motion at postoperative1 year

Contacts

Primary ContactYong In, MD, PhD
iy1000@catholic.ac.kr821090445228
Backup ContactMansoo Mansoo, MD, PhD
kms3779@naver.com821072333875

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026